2. Academic Validation
  3. Novel Imidazopyridazine Compounds as IL-17 Inhibitors for Treating Inflammatory Diseases

Novel Imidazopyridazine Compounds as IL-17 Inhibitors for Treating Inflammatory Diseases

  • ACS Med Chem Lett. 2025 Nov 20;16(12):2403-2404. doi: 10.1021/acsmedchemlett.5c00679.
Ram W Sabnis 1
Affiliations

Affiliation

  • 1 Arclin USA LLC, 1150 Sanctuary Parkway, Suite 100, Alpharetta, Georgia 30009, United States.
PMID: 41403998 DOI: 10.1021/acsmedchemlett.5c00679
Abstract

Provided herein are novel imidazopyridazine compounds as IL-17 inhibitors, pharmaceutical compositions, use of such compounds in treating inflammatory diseases, and processes for preparing such compounds.

Figures
Products